Hannah Joseph Hospital reported a revenue of ₹92.05 Cr for the financial year ended March 31, 2026 (FY26), marking an increase of 18.73% from the previous year. The hospital's Profit After Tax (PAT) rose to ₹11.18 Cr, up from ₹7.21 Cr in FY25, reflecting a growth of 55.08%. The EBITDA for the period was recorded at ₹24.96 Cr, corresponding to a margin of 27.12%, while the Return on Equity Ratio (Average Equity) was noted at 15.00%.

The financial performance was driven by a strong operational showing, with the Average Revenue Per Occupied Bed (ARPOB) improving to ₹139 lakh in FY26 from ₹80 lakh in FY23. The hospital's total number of shares stood at 2.27 Cr, with a basic and diluted EPS of ₹6.32. The net worth of the company increased to ₹97.37 Cr as of March 31, 2026.

Financial Highlights

The company's revenue growth rate for FY26 was 18.73%, following a 22.27% growth in FY25. The PAT margin improved to 12.15% in FY26 from 9.30% in the previous year. The price to book value was recorded at ₹42.89.

Operational Metrics

The hospital reported a capacity utilization of 43.00% in FY26, up from 34.63% in FY23. The Average Bed Occupancy was 57 beds in FY26. Revenue per bed per day increased to ₹38,000 in FY26 from ₹22,000 in FY23.

Strategic Developments

Hannah Joseph Hospital outlined its opportunity for expansion into a Radiation Oncology Centre, leveraging its expertise in neurosciences. The company has acquired adjacent land for a dedicated oncology campus. The hospital also highlighted its technology edge, including the BrainLab Navigation System and DTI Fiber Tracking 3.0 (AI) for surgical precision.

Surgical growth was evident, with Neurosurgery cases increasing to 402 in FY26 from 303 in 2022-23. Orthopaedic and Trauma cases rose to 236 in FY26 from 59 in 2022-23. The overall surgical growth was reported at 16.80%.

Hannah Joseph Hospital has fixed Wednesday, July 08, 2026, as the record date to determine shareholder eligibility for a final dividend of ₹2 per equity share for the financial year 2025-26. The dividend, recommended by the Board of Directors on May 29, 2026, represents 20% on the face value of ₹10 each and is subject to approval at the 15th Annual General Meeting (AGM). If approved, the payout will be made within 30 days from the date of declaration.

The AGM is scheduled for Wednesday, July 15, 2026, at 12:00 Noon IST via video conferencing. The deemed venue is the Corporate Office at R.S. No. 115/3B2, 116/1A2, Madurai–Tuticorin Ring Road, Chinthamani, Madurai – 625009, Tamil Nadu. The company has also fixed July 08, 2026, as the cut-off date to ascertain eligibility for members entitled to vote through electronic means.

Shareholders holding shares in dematerialised form will receive the dividend if their names appear in the beneficial ownership statements provided by NSDL and CDSL as of the record date. The remote e-voting period will commence on July 12, 2026, at 9:00 A.M. IST and conclude on July 14, 2026, at 5:00 P.M. IST. The intimation was submitted to BSE Limited pursuant to Regulation 30 and Regulation 42 of the SEBI (LODR) Regulations, 2015.

Key AGM and Dividend Details